Trovagene Q3 Revenues Increase as It Nears Test Launch | GenomeWeb

NEW YORK (GenomeWeb News) – Trovagene today reported that its third-quarter revenues climbed to $211,000 from $55,000, as the firm nears the launch of its first molecular diagnostic tests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.